Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 5117 [2015-01765]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices
novel influenza (H5N1) vaccines, tetanus,
diphtheria, and acellular pertussis (Tdap)
vaccine; hepatitis vaccines; new hexavalent
vaccine work group; yellow fever vaccine;
smallpox vaccine in laboratory personnel;
and vaccine supply. Recommendation votes
are scheduled for general recommendations,
meningococcal vaccines, influenza, novel
influenza H5N1 vaccine, yellow fever
vaccine, smallpox vaccine, and human
papillomavirus vaccines. Time will be
available for public comment.
Agenda items are subject to change as
priorities dictate.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30333, telephone 404/639–
8836; Email ACIP@CDC.GOV.
Meeting is webcast live via the World Wide
Web; for instructions and more information
on ACIP please visit the ACIP Web site:
https://www.cdc.gov/vaccines/acip/
index.html.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–01818 Filed 1–29–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
asabaliauskas on DSK5VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5:00 p.m.,
Eastern Time, February 27, 2015.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
VerDate Sep<11>2014
20:33 Jan 29, 2015
Jkt 235001
joining the teleconference at the USA tollfree, dial-in number is 1–866–659–0537 and
the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort.
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for the
Subcommittee meeting includes the
following dose reconstruction program
quality management and assurance activities:
Discussion of current findings from NIOSH
and Advisory Board dose reconstruction
blind reviews; discussion of dose
reconstruction cases under review including
Pacific Proving Grounds, DuPont Deepwater
Works, and cases from Sets 14–18; the Oak
Ridge sites (Y–12, K–25, Oak Ridge National
Laboratory, and Savannah River Site); plans
for dose reconstruction case reviews; and
preparation of the Advisory Board’s next
report to the Secretary, HHS, summarizing
the results of completed dose reconstruction
reviews. The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore Katz, Designated Federal Officer,
NIOSH, CDC, 1600 Clifton Road NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (513) 533–6800, Toll Free
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
5117
1(800)CDC–INFO, Email ocas@cdc.gov. The
Director, Management Analysis and Services
Office, has been delegated the authority to
sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–01765 Filed 1–29–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns ‘‘Epi-Centers for the
Prevention of Healthcare-Associated
Infections, Antimicrobial Resistance and
Adverse Events-Multicenter Expansion
of Current Investigation’’, Funding
Opportunity Announcement (FOA)
CK11–0010501SUPP15, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:00 p.m.–4:00 p.m.,
February 23, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epi-Centers for the Prevention
of Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events-Multicenter Expansion of Current
Investigation’’, FOA CK11–0010501SUPP15’’.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833. The Director,
Management Analysis and Services Office,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5117]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01765]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.-5:00 p.m., Eastern Time, February 27,
2015.
Place: Audio Conference Call via FTS Conferencing.
Status: Open to the public, but without a public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of
the meeting. The public is also welcome to listen to the meeting by
joining the teleconference at the USA toll-free, dial-in number is
1-866-659-0537 and the pass code is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort.
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: The Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters for Discussion: The agenda for the Subcommittee meeting
includes the following dose reconstruction program quality
management and assurance activities: Discussion of current findings
from NIOSH and Advisory Board dose reconstruction blind reviews;
discussion of dose reconstruction cases under review including
Pacific Proving Grounds, DuPont Deepwater Works, and cases from Sets
14-18; the Oak Ridge sites (Y-12, K-25, Oak Ridge National
Laboratory, and Savannah River Site); plans for dose reconstruction
case reviews; and preparation of the Advisory Board's next report to
the Secretary, HHS, summarizing the results of completed dose
reconstruction reviews. The agenda is subject to change as
priorities dictate.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20,
Atlanta, Georgia 30333, Telephone (513) 533-6800, Toll Free
1(800)CDC-INFO, Email ocas@cdc.gov. The Director, Management
Analysis and Services Office, has been delegated the authority to
sign Federal Register notices pertaining to announcements of
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-01765 Filed 1-29-15; 8:45 am]
BILLING CODE 4163-18-P
